A patient centric model (Just-In-Time) enrolls 36% more patients per month with 52% fewer sites and with an estimated site-cost savings of $109,500 when compared to traditional enrollment models.
A patient-first clinical trial enrollment model, Just-In-Time (JIT), used in community practices, was compared to traditional enrollment, used in large hospitals. This study demonstrates that overall enrollment in community sites can be 52% more efficient than in large hospitals, when the JIT model is applied. Costs were favorable for JIT.
Pharmatech Oncology’s Just-In-Time enrollment methodology increases enrollment by 63% while mitigating financial risk for sponsors when directly compared to a non-specialized global CRO.
Pharmatech Oncology coordinated multi-center plan involving our experienced investigators, the study was finished 8 months ahead of its revised target date, and with a cost savings to the sponsor of several hundred thousand dollars.